Please assess the completion status of the following clinical trial:

Trial Title: SUPARTZ Versus Placebo in Osteoarthritis of the Shoulder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Glenohumeral Osteoarthritis (OA) confirmed by radiograph~* Limitation of shoulder motion in at least one direction~* Retained active range of motion of at least 30% in all directions~Exclusion Criteria:~* Full thickness rotator cuff tear or rotator cuff tendinopathy~* Frozen shoulder~* Female who is pregnant or lactating

- Gender: ALL
- Minimum Age: 35 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Supartz (Type: ACTIVE_COMPARATOR): SUPARTZ® 3 injections over 2 weeks
- Phosphate Buffered Saline (Type: PLACEBO_COMPARATOR): Phosphate Buffered Saline 3 injections over 2 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).